Tilray Brands, Inc. TLRY
Nasdaq · stock · Medicinal Chemicals & Botanical Products · website · IPO 2018-07-19
Tilray Brands, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 28.4% | 29.3% | 28.3% | 23.4% | 18.6% | 24.0% | 11.7% | 23.7% | -14.1% | 33.1% |
| Operating margin | -6.9% | -277.9% | -22.1% | -218.4% | -97.1% | -25.8% | -95.6% | -25.7% | -182.1% | -134.1% |
| Net margin | -13.3% | -266.3% | -31.1% | -231.6% | -75.9% | -71.6% | -128.8% | -25.3% | -192.3% | -157.0% |
| FCF margin | — | — | — | — | — | — | -82.7% | — | -198.7% | -223.6% |
| Return on assets | -5.2% | -105.4% | -5.8% | -33.7% | -8.7% | -6.1% | -28.7% | -5.9% | -35.8% | -10.3% |
| Return on equity | -7.5% | -144.7% | -7.1% | -43.6% | -10.7% | -8.2% | -72.5% | -8.0% | -112.6% | -34.3% |
| Debt / equity | — | — | — | — | 0.04× | 0.05× | — | 0.07× | — | — |
| Current ratio | 2.21 | 2.46 | 2.27 | 1.79 | 2.87 | 2.20 | 1.91 | 4.85 | 2.80 | 21.37 |
Computed from company filings · US · as of 2025-05-31. Facts plus Stocktoria's own computed scores — not investment advice.